BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31128406)

  • 1. Concentration of microtubule associated protein tau (MAPT) in urine and saliva as a potential biomarker of traumatic brain injury in relationship with blood-brain barrier disruption in postmortem examination.
    Olczak M; Poniatowski ŁA; Niderla-Bielińska J; Kwiatkowska M; Chutorański D; Tarka S; Wierzba-Bobrowicz T
    Forensic Sci Int; 2019 Aug; 301():28-36. PubMed ID: 31128406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau protein (MAPT) as a possible biochemical marker of traumatic brain injury in postmortem examination.
    Olczak M; Niderla-Bielińska J; Kwiatkowska M; Samojłowicz D; Tarka S; Wierzba-Bobrowicz T
    Forensic Sci Int; 2017 Nov; 280():1-7. PubMed ID: 28942078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-mortem detection of neuronal and astroglial biochemical markers in serum and urine for diagnostics of traumatic brain injury.
    Olczak M; Poniatowski ŁA; Siwińska A; Kwiatkowska M
    Int J Legal Med; 2023 Sep; 137(5):1441-1452. PubMed ID: 37272985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunolocalization of dynein, dynactin, and kinesin in the cerebral tissue as a possible supplemental diagnostic tool for traumatic brain injury in postmortem examination.
    Olczak M; Poniatowski Ł; Kwiatkowska M; Samojłowicz D; Tarka S; Wierzba-Bobrowicz T
    Folia Neuropathol; 2019; 57(1):51-62. PubMed ID: 31038188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-originated peptides as possible biochemical markers of traumatic brain injury in cerebrospinal fluid post-mortem examination.
    Olczak M; Kwiatkowska M; Niderla-Bielińska J; Chutorański D; Tarka S; Wierzba-Bobrowicz T
    Folia Neuropathol; 2018; 56(2):97-103. PubMed ID: 30509029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum and urine levels of progranulin (PGRN) as a predictor of microglia activation in the early phase of traumatic brain injury: a further link with the development of neurodegenerative diseases.
    Olczak M; Poniatowski ŁA; Siwińska A; Kwiatkowska M; Chutorański D; Wierzba-Bobrowicz T
    Folia Neuropathol; 2021; 59(1):81-90. PubMed ID: 33969679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-mortem biochemistry of NSE and S100B: A supplemental tool for detecting a lethal traumatic brain injury?
    Sieber M; Dreßler J; Franke H; Pohlers D; Ondruschka B
    J Forensic Leg Med; 2018 Apr; 55():65-73. PubMed ID: 29471249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of Cerebral Biomarkers Proving Traumatic Brain Injuries in Post-Mortem Body Fluids.
    Ondruschka B; Sieber M; Kirsten H; Franke H; Dreßler J
    J Neurotrauma; 2018 Sep; 35(17):2044-2055. PubMed ID: 29732941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the risk of traumatic brain injury and evaluation neurogranin and myelin basic protein as potential biomarkers of traumatic brain injury in postmortem examination.
    Shang Y; Wang Y; Guo Y; Ren L; Zhang X; Wang S; Zhang C; Cai J
    Forensic Sci Med Pathol; 2022 Sep; 18(3):288-298. PubMed ID: 35201602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin basic protein and neurofilament H in postmortem cerebrospinal fluid as surrogate markers of fatal traumatic brain injury.
    Bohnert S; Wirth C; Schmitz W; Trella S; Monoranu CM; Ondruschka B; Bohnert M
    Int J Legal Med; 2021 Jul; 135(4):1525-1535. PubMed ID: 33895854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Caspase-3-Mediated Apoptosis in Chronic Caspase-3-Cleaved Tau Accumulation and Blood-Brain Barrier Damage in the Corpus Callosum after Traumatic Brain Injury in Rats.
    Glushakova OY; Glushakov AO; Borlongan CV; Valadka AB; Hayes RL; Glushakov AV
    J Neurotrauma; 2018 Jan; 35(1):157-173. PubMed ID: 28637381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleaved-tau: a biomarker of neuronal damage after traumatic brain injury.
    Gabbita SP; Scheff SW; Menard RM; Roberts K; Fugaccia I; Zemlan FP
    J Neurotrauma; 2005 Jan; 22(1):83-94. PubMed ID: 15665604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of MAPT enhances the effect of bexarotene and attenuates the damage after traumatic brain injury using in vivo and in vitro experiments.
    Dong H; Wang H; Wang L
    Folia Neuropathol; 2020; 58(3):253-264. PubMed ID: 33099295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective pilot study on serum cleaved tau protein as a neurological marker in severe traumatic brain injury.
    Pandey S; Singh K; Sharma V; Pandey D; Jha RP; Rai SK; Chauhan RS; Singh R
    Br J Neurosurg; 2017 Jun; 31(3):356-363. PubMed ID: 28293977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute phase response after fatal traumatic brain injury.
    Ondruschka B; Schuch S; Pohlers D; Franke H; Dreßler J
    Int J Legal Med; 2018 Mar; 132(2):531-539. PubMed ID: 29306988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traumatic Brain Injury in hTau Model Mice: Enhanced Acute Macrophage Response and Altered Long-Term Recovery.
    Kokiko-Cochran ON; Saber M; Puntambekar S; Bemiller SM; Katsumoto A; Lee YS; Bhaskar K; Ransohoff RM; Lamb BT
    J Neurotrauma; 2018 Jan; 35(1):73-84. PubMed ID: 28859549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMEM119 as a specific marker of microglia reaction in traumatic brain injury in postmortem examination.
    Bohnert S; Seiffert A; Trella S; Bohnert M; Distel L; Ondruschka B; Monoranu CM
    Int J Legal Med; 2020 Nov; 134(6):2167-2176. PubMed ID: 32719959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mdivi-1 alleviates blood-brain barrier disruption and cell death in experimental traumatic brain injury by mitigating autophagy dysfunction and mitophagy activation.
    Wu Q; Gao C; Wang H; Zhang X; Li Q; Gu Z; Shi X; Cui Y; Wang T; Chen X; Wang X; Luo C; Tao L
    Int J Biochem Cell Biol; 2018 Jan; 94():44-55. PubMed ID: 29174311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forensic biomarkers of lethal traumatic brain injury.
    Zwirner J; Kulakofsky R; Fitzek A; Schröder AS; Bohnert S; Franke H; Renné T; Tse R; Ondruschka B
    Int J Legal Med; 2022 May; 136(3):871-886. PubMed ID: 35226180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CNS Injury: Posttranslational Modification of the Tau Protein as a Biomarker.
    Caprelli MT; Mothe AJ; Tator CH
    Neuroscientist; 2019 Feb; 25(1):8-21. PubMed ID: 29283022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.